Nurix Therapeutics
NRIX
NRIX
128 hedge funds and large institutions have $352M invested in Nurix Therapeutics in 2023 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 41 increasing their positions, 51 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
19% less capital invested
Capital invested by funds: $436M → $352M (-$83.2M)
20% less repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 51
Holders
128
Holding in Top 10
–
Calls
$104K
Puts
$88K
Top Buyers
| 1 | +$6.4M | |
| 2 | +$2.61M | |
| 3 | +$2.47M | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$1.57M |
| 5 |
Charles Schwab
San Francisco,
California
|
+$1.45M |
Top Sellers
| 1 | -$3.14M | |
| 2 | -$2.8M | |
| 3 | -$2.4M | |
| 4 |
Nomura Holdings
Tokyo,
Japan
|
-$1.3M |
| 5 |
State Street
Boston,
Massachusetts
|
-$1.19M |